Many of the biotech stocks remain outside of Mr. Market's interest zone. Check out five biotech firms that may be of interest ...

Alvotech ( ($ALVO) ) just unveiled an announcement. On October 6, 2025, Alvotech announced that the European Medicines Agency accepted a Marketing ...

Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe and Alvotech ...

Alvotech ALVO is rapidly scaling its presence in the biosimilar/generic market, thanks to its partnership-driven model. Under this approach, the company focuses on development and manufacturing, while ...

EMA accepts marketing authorization application for AVT23, a proposed biosimilar to Xolair: London, UK Tuesday, October 7, 2025, 16:00 Hrs [IST] Advanz Pharma Holdco Limited (Adva ...

Alvotech (NasdaqGM:ALVO) has caught some attention in the biotech space recently, especially given its stock movement over the past month. With a 3% increase in that period, investors are wondering ...

On January 27, 2025, Alvotech and Teva announced FDA acceptance of the Biologics License Application (BLA) for AVT05, a proposed biosimilar to SIMPONI and SIMPONI ARIA. This marks the first U.S. BLA ...

Alvotech ALVO makes biosimilar versions of branded medicines that have gone off-patent. The year 2024 has been transformational for Alvotech as it marked a gradual transition of ALVO from an R&D ...

Alvotech recently submitted a Citizen Petition to the FDA requesting that the agency refuse to license any ustekinumab biosimilar as interchangeable with STELARA if it is manufactured using a Chinese ...

Alvotech has a current portfolio of eight products and product candidates targeting autoimmune disease, eye disorders, respiratory disease, and cancer. The company has successfully launched its ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Medicines Agency’s ...

REYKJAVIK, Iceland--(BUSINESS WIRE)--Alvotech Holdings S.A. (“Alvotech”), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients ...